Preventing Superbugs and Protecting Patients Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to identify types of medical devices for which premarket notification must include proposed labeling, including validated instructions regarding cleaning, disinfection, and sterilization.
The FDA must issue final guidance regarding when a premarket notification is required for a modification to a medical device.| Action Date | Type | Text | Source |
|---|---|---|---|
| 2016-04-05 | Calendars | Placed on Senate Legislative Calendar under General Orders. Calendar No. 417. | Senate |
| 2016-04-05 | Committee | Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report. | Senate |
| 2016-02-09 | Committee | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. | Senate |
| 2016-02-04 | IntroReferral | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate |
| 2016-02-04 | IntroReferral | Introduced in Senate | Library of Congress |